8:30 – 9:00 am EDT – Continental Breakfast and Registration
9:00 – 10:30 am EDT – Program
McDermott Will & Emery
The McDermott Building
500 North Capitol Street, N.W.
Washington, DC 20001
Join Gene Quinn, editor of IPWatchdog, and Bernie Knight, partner at McDermott Will & Emery, along with the below confirmed participants, for a roundtable discussion on the pros and cons of the alternate versions of patent reform legislation.
Chief Judge Paul Redmond Michel, CAFC (retired)
Herbert C. Wamsley, Executive Director, Intellectual Property Owners Association
Louis Foreman, Founder and CEO, Enventys
John M. Whealan, Dean for Intellectual Property Law Studies, George Washington University Law School
John R. Thomas, Professor, Georgetown University Law Center
David Ruschke, Chief Patent Counsel, Medtronic CardioVascular
Phil Hartstein, President and CEO, Finjan
Hans Sauer, Deputy General Counsel for Intellectual Property, BIO
Senators Coons (D-DE), Durbin (D-IL) and Hirono (D-HI) have submitted an alternative to the Innovation Act, which was re-introduced by Congressman Goodlatte (R-VA) to this Congress earlier in 2015. Both pieces of legislation stand in sharp contrast to one another and present differing visions of the patent system. And if Senator Grassley introduces his own bill in April as expected, we will also discuss its provisions.
The Support Technology and Research for Our Nation’s Growth Patents Act (STRONG Patents Act) introduced by Senators Coons, Durbin and Hirono is supported by the Biotechnology Industry Organization, the Innovation Alliance and several major university groups, including the Association of American Universities. This legislation, overwhelmingly favorable to innovators and patent owners, would make changes to the post-grant administrative process, eliminate the diversion of U.S. Patent and Trademark Office (USPTO) fees and make it easier to obtain damages for willful infringement, among other things. In contrast, the Innovation Act submitted in the House by Congressman Goodlatte primarily focuses on curbing litigation abuses of non-practicing entities by heightening pleading standards, changing to a loser-pays system and making it easier to stay litigation proceedings. Some see the Goodlatte legislation as weakening the patent right by making it more difficult to enforce ones patents rights.
We hope you will join us for this lively roundtable.
In order to promote a frank and open discussion of the issue, attendance may be limited for this event.
Gene Quinn, Editor, IPWatchdog
Bernard J. Knight, Jr., Partner, McDermott Will & Emery LLP
Please be advised McDermott has the right to restrict attendance and may limit participation in this event.